Earlier this year, we announced work on our Manifesto for Cancer Research & Care– a blueprint made up of clear, actionable long-term policies to ...

Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.

Shay Elkins, a patient with metastatic triple-negative breast cancer, discussed her experience with second-line treatment. Dr. Noor provided insights into ...

Practical advice for improving clinical trials to ensure they are more reflective of the overall population of patients with prostate cancer.

Dr. Noor Abuhadra and patient Shay Elkins discuss overcoming barriers to cancer treatment access and reimbursement. Shay shares her relatively smooth ...

Understanding which of the three types of myeloproliferative neoplasms (MPNs) a patient has can help guide them to receive the appropriate treatment and ...

Patients with prostate cancer tend to live a long time after being diagnosed. In fact, according to the American Cancer Society, the five-year relative ...

More than half of long-term breast cancer survivors experience medium to high symptom burden years after treatment, according to findings from a recent ...

Transcript:How do you educate patients and caregivers in your practice about prostate cancer?Alicia Morgans, M.D., MPH: When patients and their caregivers ...

Being on the other side of the diagnosis completely changed my perspective. Before my diagnosis, I had always assumed that being a cancer survivor meant ...